We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.33%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$107B
AUM Growth
-$4.74B
(-4.2%)
Cap. Flow
-$4.5B
Cap. Flow
% of AUM
-4.19%
Top 10 Holdings %
Top 10 Hldgs %
16.64%
Holding
4,289
New
314
Increased
1,937
Reduced
1,469
Closed
342
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$731M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$547M |
| 3 |
AABA
Altaba Inc
AABA
|
+$213M |
| 4 |
QEP
QEP RESOURCES, INC.
QEP
|
+$196M |
| 5 |
Alibaba
BABA
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.54B |
| 2 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
+$959M |
| 3 |
Citigroup
C
|
+$339M |
| 4 |
Apple
AAPL
|
+$337M |
| 5 |
EQT Corp
EQT
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.27% |
| 2 | Financials | 11.39% |
| 3 | Healthcare | 9.26% |
| 4 | Consumer Discretionary | 6.73% |
| 5 | Industrials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACFC
3626
DELISTED
Atlantic Coast Financial Corporation
ACFC
| $125K | ﹤0.01% |
12,103
-12,055
| -50% | -$125K |
|
|
AXAS
3627
DELISTED
Abraxas Petroleum Corp
AXAS
| $124K | ﹤0.01% |
2,806
+524
| +23% | +$24.4K |
|
|
INSY
3628
DELISTED
Insys Therapeutics, Inc.
INSY
| $124K | ﹤0.01% |
20,460
-61,468
| -75% | -$508K |
|
3629
Calumet Specialty Products
CLMT
$3.85B
| $123K | ﹤0.01% |
17,414
+3,558
| +26% | +$26.3K |
|
3630
Digi International
DGII
$2.63B
| $121K | ﹤0.01% |
11,756
+1,069
| +10% | +$11.1K |
|
3631
iShares Global Clean Energy ETF
ICLN
$2.31B
| $121K | ﹤0.01% |
12,722
| – | – |
|
3632
Global X Uranium ETF
URA
$5.42B
| $121K | ﹤0.01% |
10,000
| – | – |
|
3633
Western New England Bancorp
WNEB
$259M
| $120K | ﹤0.01% |
+11,279
| New | +$119K |
|
|
DS
3634
DELISTED
Drive Shack Inc.
DS
| $120K | ﹤0.01% |
25,168
-4,635
| -16% | -$23.7K |
|
|
AENZ
3635
DELISTED
Aenza S.A.A.
AENZ
| $117K | ﹤0.01% |
12,847
+5,202
| +68% | +$43K |
|
3636
DHT Holdings
DHT
$2.99B
| $116K | ﹤0.01% |
34,281
+1,510
| +5% | +$5.61K |
|
|
DRRX
3637
DELISTED
DURECT Corp
DRRX
| $116K | ﹤0.01% |
5,423
+1,319
| +32% | +$18.4K |
|
3638
Harmonic Inc
HLIT
$1.25B
| $116K | ﹤0.01% |
30,600
-3,487
| -10% | -$12.7K |
|
3639
Costamare
CMRE
$1.88B
| $114K | ﹤0.01% |
18,288
+1,714
| +10% | +$10.8K |
|
3640
Calix
CALX
$2.26B
| $113K | ﹤0.01% |
16,591
+3,627
| +28% | +$23.4K |
|
|
LKM
3641
DELISTED
Link Motion Inc.
LKM
| $113K | ﹤0.01% |
68,280
+12,085
| +22% | +$33.4K |
|
|
SBBP
3642
DELISTED
Strongbridge Biopharma plc.
SBBP
| $112K | ﹤0.01% |
+12,681
| New | +$94.9K |
|
|
MCBC
3643
DELISTED
Macatawa Bank Corp
MCBC
| $111K | ﹤0.01% |
10,802
+372
| +4% | +$3.79K |
|
|
ATRS
3644
DELISTED
Antares Pharma, Inc.
ATRS
| $111K | ﹤0.01% |
50,417
+8,984
| +22% | +$20.2K |
|
3645
Lineage Cell Therapeutics
LCTX
$269M
| $110K | ﹤0.01% |
46,780
+7,779
| +20% | +$18.2K |
|
3646
Option Care Health
OPCH
$3.45B
| $107K | ﹤0.01% |
10,818
+175
| +2% | +$2.02K |
|
|
PVLA
3647
Palvella Therapeutics
PVLA
$1.99B
| $106K | ﹤0.01% |
195
+68
| +54% | +$42.1K |
|
|
BLCM
3648
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $106K | ﹤0.01% |
1,615
+240
| +17% | +$18.1K |
|
|
NPTN
3649
DELISTED
NEOPHOTONICS CORP
NPTN
| $105K | ﹤0.01% |
15,338
+5,053
| +49% | +$32.1K |
|
|
WOW
3650
DELISTED
WideOpenWest
WOW
| $104K | ﹤0.01% |
14,560
+4,173
| +40% | +$40.1K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2018 Portfolio in Review
As of Q1 2018, Credit Suisse held 4,289 positions worth $107B, down 4.2% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $4.5B in Q1 2018, closing 342 positions and reducing 1,469 holdings. Its most notable exit was VelocityShares Daily Inverse VIX Short Term ETN, an estimated $959M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Credit Suisse opened a new position in Cambria Shareholder Yield ETF worth $75.4M.
- Credit Suisse's largest Q1 2018 buy was Cambria Shareholder Yield ETF: 2,000,000 shares worth $75.4M.
- Credit Suisse added most to iShares Core S&P Mid-Cap ETF in Q1 2018, an estimated $731M increase.
- Credit Suisse's biggest Q1 2018 reduction was UnitedHealth, cutting an estimated $1.54B.
- Credit Suisse fully exited VelocityShares Daily Inverse VIX Short Term ETN in Q1 2018, selling an estimated $959M.
- Credit Suisse's ten largest holdings make up 17% of its $107B portfolio in Q1 2018.
- Credit Suisse opened 314 new positions and closed 342 in Q1 2018.
- Credit Suisse's portfolio value fell 4.2% quarter-over-quarter to $107B.
Based on Credit Suisse's 13F filing for Q1 2018, filed 15 May 2018.